Skip to content

Drug interactions

Felbamate + Linagliptin

Severity: Minor

Felbamate and Linagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Felbamate is a weak inducer of CYP3A4, so it could modestly lower linagliptin exposure. The legacy direction (increased levels) is not consistent with induction, and any effect is unlikely to matter clinically because linagliptin is mostly eliminated unchanged.

What this interaction means in plain words

Felbamate and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Felbamate belongs to Central Nervous System; Linagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by felbamate may slightly increase linagliptin metabolism; the effect is predicted rather than well documented.

What to do

No routine dose change is needed; check glycemic control (HbA1c, fasting glucose) if felbamate is started or stopped.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Felbamate and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Felbamate with Linagliptin?

MediHelp rates the interaction as minor. Felbamate and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Felbamate is a weak inducer of CYP3A4, so it could modestly lower linagliptin exposure. The legacy direction (increased levels) is not consistent with induction, and any effect is unlikely to matter clinically because linagliptin is mostly eliminated unchanged.

How serious is the interaction between Felbamate and Linagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; check glycemic control (HbA1c, fasting glucose) if felbamate is started or stopped.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in